publication . Article . 2013

Mortalidad intrahospitalaria por accidente cerebrovascular

Federico Rodríguez Lucci; Virginia Pujol Lereis; Sebastián Ameriso; Guillermo Povedano; María F. Díaz; Alejandro Hlavnicka; Néstor A. Wainsztein; Sebastián F. Ameriso;
Open Access English
  • Published: 01 Aug 2013 Journal: Medicina (Buenos Aires) (issn: 1669-9106, Copyright policy)
  • Publisher: Fundación Revista Medicina
Abstract
La mortalidad global por accidente cerebrovascular (ACV) ha disminuido en las últimas tres décadas, probablemente debido a un mejor control de los factores de riesgo vascular. La mortalidad hospitalaria por ACV ha sido tradicionalmente estimada entre 6 y 14% en la mayoría de las series comunicadas. Sin embargo, los datos de ensayos clínicos recientes sugieren que esta cifra sería sustancialmente menor. Se revisaron datos de pacientes internados con diagnóstico de ACV del Banco de Datos de Stroke de FLENI y los registros institucionales de mortalidad entre los años 2000 y 2010. Los subtipos de ACV isquémicos se clasificaron según criterios TOAST y los ACV hemorrá...
Subjects
free text keywords: Mortalidad intrahospitalaria, Accidente cerebrovascular isquémico, Accidente cerebrovascular hemorrágico, Medicine, R, Immunologic diseases. Allergy, RC581-607, Infectious and parasitic diseases, RC109-216
Download from
26 references, page 1 of 2

1. The World Health Report 2000. Health systems: improving performance. Geneva: World Health Organization, 2000. En: www.who.int/whr/2000/en/; consultado 15/8/2010.

2. World Health Organization. Global Burden of Diseased Deaths, Years of Life Lost and Years Lost Due to Di - sability. En: http://appswhoint/ghodata/?vid¼72063; consultado 26/8/2010.

3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.

4. Sposato LA, Esnaola MM, Zamora R, Zurrú MC, Fustinoni O, Saposnik G. ReNACer Investigators and the Argentinian Neurological Society. Quality of ischemic stroke care in emerging countries: the Argentinian National Stroke Registry (ReNACer). Stroke 2008; 39: 3036-41.

5. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000; 2831151-8.

6. Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology 1998; 50341-50.

7. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke. A randomized controlled trial. JAMA 1998; 279: 1265-72.

8. Saposnik G, Hill MD, O'Donnell M, Fang J, Hachinski V, Kapral MK; Registry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working Group. Variables associated with 7-day, 30-day and 1-year fatality after ischemic stroke. Stroke 2008; 39: 2318-24.

9. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classifica - tion of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.

10. Rojas JI, Zurru MC, Patrucco L, Romano M, Riccio PM, Cristiano E. Registro de enfermedad cerebrovascular isquémica. Medicina (B Aires) 2006; 66: 547-51.

11. Rotta Escalante R, Lourido M, Melcón C, Curatolo L. Accidente Cerebrovascular en la Policlínica Bancaria: Registro de 1699 Eventos Consecutivos. Revista Neurológica Argentina 2003; 28: 91-95.

12. Retamal E, Castro A, Espinoza M, Veas E, Retamal J, González-Hernández J. Características clínicas de la enfermedad cerebrovascular aguda y factores asociados a mortalidad en el hospital de urgencia y asistencia pú- blica. Revista Memoriza.com 2010; 6: 32-39. En: www. memoriza.com/; consultado el 26/08/12.

13. Castañeda-Guarderas A, Beltrán-Ale G, Casma-Bustamante R, Ruiz-Grosso P, Málaga G. Registry of patients with stroke stated in a public hospital of Peru, 2000-2009. Rev Peru Med Exp Salud Publica 2011; 28: 623-7.

14. Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke 1996; 27: 1937-43. [OpenAIRE]

15. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172(danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279: 1265-72.

26 references, page 1 of 2
Any information missing or wrong?Report an Issue